Clorox
At a glance
Clorox reported 2025 revenue of $7.1B, up 0.2% from $7.09B in 2024. Over 4 years since 2021 ($7.34B), that is a decline of about 0.8% a year. Revenue peaked in 2023 at $7.39B.
In the last 12 months 1 insider reported 2 open-market purchases ($846K) and 0 sales. The largest was a purchase of $429K by Director Pierre R Breber on May 5, 2026.
Clorox filed 12 current reports (Form 8-K) in the last 12 months, most often for results of operations (4), officer or director change (3), other events (3) and regulation fd disclosure (2). The latest officer or director change was reported on Oct 29, 2026. It reported a material agreement or a completed acquisition or disposal 1 time.
2 of the 20 investors tracked here held Clorox at the last quarter end, worth $3.7M combined. It is the largest weight for Bridgewater Associates (0% of its portfolio), followed by National Pension Service (Korea) (0%). Added: National Pension Service (Korea). Reduced: Bridgewater Associates.
Annual results
| Year | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Net income | $710M | $471M | $161M | $292M | $824M |
| Diluted EPS | $5.58 | $3.73 | $1.20 | $2.25 | $6.52 |
| Dividend per share | $4.49 | $3.48 | $4.72 | $4.80 | $4.88 |
Fiscal year ends Jun 30 · incorporated in DE
Tracked investors holding (13F)
Weight is the share of each investor's portfolio, as of the quarter end.
Current reports (8-K, last 12 months)
Insider open-market trades (last 12 months)
Source: SEC EDGAR. How figures are combined